Locations of interest | |
Credentials | None |
Scientist
Ability to pursue novel approaches to remaining problems in disease management
Orig3n, PatientsLikeMe
(Frustrating) Limited resources
(Rewarding) Ability to follow leads that would be dropped elsewhere
Lack of conviction in approach
Focus, external input, lean infrastructure
Matthew Burkhardt has worked in the academic and industrial sectors at startup and pharma levels to develop in vitro disease models for drug discovery. The majority of this work has been done in the neurodegenerative disease areas (AD, ALS) and cardio-related fields (rare diseases).